Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

chromophobe adenoma - Clinical Profile, Treatments & Trials | Kisho | Kisho

Rare Disease

chromophobe adenoma

MONDO:0006701

Also known as:chromophobe adenoma of pituitary glandchromophobe adenoma of the pituitary glandpituitary chromophobe adenoma

Overview

An epithelial neoplasm of the anterior pituitary gland in which the neoplastic cells do not stain with acidic or basic dyes.

Treatments1 FDA approved

ResearchLimited published research (2 articles)

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

1 FDA-approved treatment is available for chromophobe adenoma, including ARGININE HYDROCHLORIDE (R-GENE, approved 1973).

Approved Therapies

Brand Name	Generic Name	Mechanism	Approved	Market Status

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for chromophobe adenoma.

2 publications have been identified in PubMed for chromophobe adenoma. Research spans Basic Science / Preclinical (50%) and Epidemiology / Natural History (50%).

Recent Publications

Fukuma Y (2026). [PMID: 41457354](https://pubmed.ncbi.nlm.nih.gov/41457354/). *Toxicol Pathol*. [Basic Science / Preclinical]
Lounová V (2024). [PMID: 39174947](https://pubmed.ncbi.nlm.nih.gov/39174947/). *BMC Urol*. [Epidemiology / Natural History]

Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 12:33 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→What are the benefits and potential side effects of R-GENE for managing chromophobe adenoma?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

chromophobe adenoma

Overview

Treatment

Approved Therapies

Research Landscape

Recent Publications

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials